Targeting death receptors in bladder, prostate and renal cancer.
about
Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Clerodane diterpenes from Casearia arguta that act as synergistic TRAIL sensitizersThe Histone Deacetylase Inhibitor Trichostatin A Sensitizes Human Renal Carcinoma Cells to TRAIL-Induced Apoptosis through Down-Regulation of c-FLIPL.A cell-based high-throughput screen to identify synergistic TRAIL sensitizers.Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.The role of c-FLIP splice variants in urothelial tumours.Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.Correlation and Significance of Urinary Soluble Fas and Vascular Endothelial Growth Factor in Bladder Urothelial CancerTargeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Repression of NF-kappaB and activation of AP-1 enhance apoptosis in prostate cancer cells.Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylationMultifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy.Prevalence and correlations of lower urinary tract symptoms, erectile dysfunction and incontinence in men from a multiethnic Asian population: Results of a regional population-based survey and comparison with industrialized nations.Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression.PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens.Alginate encapsulated cells secreting Fas-ligand reduce lymphoma carcinogenicity.The potential evasion of immune surveillance in mucosa associated lymphoid tissue lymphoma by DcR2-mediated up-regulation of nuclear factor-κB.
P2860
Q34450860-87CB7AB9-D9B6-4DED-BCB0-B91B1FFE91FFQ34683833-F5F96ACF-FA4B-48CA-827B-1CD5A37FA4CCQ34865077-C0F217FD-1E81-4556-B9EF-6631EF622E7DQ35200982-7F70037F-1BA5-4EB6-A6E2-0BAF6C5602B6Q35440552-11095796-9978-4274-A09B-8E548DBC042FQ35657114-258CF9E4-06BC-46BB-A774-863D837F756AQ35850815-4F454F7C-8301-4081-BC20-22CAF3976A55Q36422922-3348F52E-9ACD-4DF7-A04C-1CDED7012680Q36500552-DBEBD915-A487-4B00-838F-9CEC9BD30B98Q37275591-EBAF07FB-C6A5-42ED-8939-49EC3C824870Q37388422-F15EB5E2-3C10-4212-BEB4-BE7DF6F23169Q39685717-3CFDEF44-72E1-4CE8-B012-8D70FA59E910Q39771272-B78F8892-AFA5-4AF5-B5A3-EC9B3221AC4FQ39774780-F84BF041-2ACA-4C11-A3D0-6F203CBFA84FQ39945831-4B9DD6D9-C6CB-43D6-819F-CCBE013070BBQ53211474-04B8E60B-1878-40BE-8BBB-B017CF1883B7Q54190979-932498FB-2982-48F6-ACBF-0A081B5914D6
P2860
Targeting death receptors in bladder, prostate and renal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Targeting death receptors in bladder, prostate and renal cancer.
@ast
Targeting death receptors in bladder, prostate and renal cancer.
@en
type
label
Targeting death receptors in bladder, prostate and renal cancer.
@ast
Targeting death receptors in bladder, prostate and renal cancer.
@en
prefLabel
Targeting death receptors in bladder, prostate and renal cancer.
@ast
Targeting death receptors in bladder, prostate and renal cancer.
@en
P2093
P1476
Targeting death receptors in bladder, prostate and renal cancer.
@en
P2093
Chris J Watson
Hugh F O'Kane
Istvan Petak
Kate E Williamson
R William G Watson
Samuel R Johnston
P304
P356
10.1016/S0022-5347(05)00160-6
P407
P577
2006-02-01T00:00:00Z